OPKO HEALTH’S MODEX THERAPEUTICS ANNOUNCES EPSTEIN-BARR VIRUS VACCINE CANDIDATE ENTERS PHASE I CLINICAL STUDY IN COLLABORATION WITH MERCK

Reuters · 01/07 13:00

Please log in to view news